2024 annual financial data
MiNK Therapeutics 2024 Financial results
Direct answer
Revenue was 0 USD.
Operating income was -10,650,239 USD and net income was -10,784,802 USD.
Operating cash flow was -9,555,476 USD.
Get free MiNK Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -10,650,239 USD
- Net income
- -10,784,802 USD
- Operating cash flow
- -9,555,476 USD
Explore related company data
View all 2024 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all MiNK Therapeutics financial years